최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Experimental & molecular medicine : EMM, v.52 no.9, 2020년, pp.1587 - 1601
Jeong, Se-Jin (Cardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO USA) , Cho, Min Ji (Biotherapeutics Translational Research Center, Korea Research Institute of Bioscience & Biotechnology, Daejeon, Republic of Korea) , Ko, Na Young (Immune and Vascular Cell Network Research Center, National Creative Initiatives, Department of Life Sciences, Ewha Womans University, Seoul, Republic of Korea) , Kim, Sinai (Immune and Vascular Cell Network Research Center, National Creative Initiatives, Department of Life Sciences, Ewha Womans University, Seoul, Republic of Korea) , Jung, In-Hyuk (Cardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO USA) , Min, Jeong-Ki (Biotherapeutics Translational Research Center, Korea Research Institute of Bioscience & Biotechnology, Daejeon, Republic of Korea) , Lee, Sang Hak (Division of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea) , Park, Jong-Gil (Biotherapeutics Translational Research Center, Korea Research) , Oh, Goo Taeg
Abdominal aortic aneurysm (AAA) is an inflammatory vascular disease characterized by structural deterioration of the aorta caused by inflammation and oxidative stress, leading to aortic dilatation and rupture. Peroxiredoxin 2 (PRDX2), an antioxidant enzyme, has been reported as a potential negative ...
1. Kent KC Clinical practice. Abdominal aortic aneurysms New Engl. J. Med. 2014 371 2101 2108 25427112
2. Benjamin EJ Heart Disease and Stroke Statistics-2018 update: a report from the American Heart Association Circulation 2018 137 e67 e492 29386200
3. Sakalihasan N Limet R Defawe OD Abdominal aortic aneurysm Lancet 2005 365 1577 1589 15866312
4. Freestone T Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm Arterioscler. Thromb. Vasc. Biol. 1995 15 1145 1151 7627708
5. Zhang J Inducible nitric oxide synthase is present in human abdominal aortic aneurysm and promotes oxidative vascular injury J. Vasc. Surg. 2003 38 360 367 12891121
6. Paik D Tilson MD Neovascularization in the abdominal aortic aneurysm. Endothelial nitric oxide synthase, nitric oxide, and elastolysis Ann. N. Y. Acad. Sci. 1996 800 277 8959013
7. Miller FJ Jr. Oxidative stress in human abdominal aortic aneurysms: a potential mediator of aneurysmal remodeling Arterioscler. Thromb. Vasc. Biol. 2002 22 560 565 11950691
8. Thomas M Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice Circulation 2006 114 404 413 16864727
9. Gavazzi G NOX1 deficiency protects from aortic dissection in response to angiotensin II Hypertension 2007 50 189 196 17502491
10. Moxon JV Diagnosis and monitoring of abdominal aortic aneurysm: current status and future prospects Curr. Probl. Cardiol. 2010 35 512 548 20932435
11. Wilmink AB Are antihypertensive drugs associated with abdominal aortic aneurysms? J. Vasc. Surg. 2002 36 751 757 12368736
12. Propanolol Aneurysm Trial Investigators. Propranolol for small abdominal aortic aneurysms: results of a randomized trial J. Vasc. Surg. 2002 35 72 79 11802135
13. Sweeting MJ Thompson SG Brown LC Greenhalgh RM Powell JT Use of angiotensin converting enzyme inhibitors is associated with increased growth rate of abdominal aortic aneurysms J. Vasc. Surg. 2010 52 1 4 20494541
14. Mastoraki ST Treatment with simvastatin inhibits the formation of abdominal aortic aneurysms in rabbits Ann. Vasc. Surg. 2012 26 250 258 22222170
15. Periard D Reduction of small infrarenal abdominal aortic aneurysm expansion rate by statins Vasa. Z. fur Gefasskrankheiten 2012 41 35 42
16. Takagi H Effects of statin therapy on abdominal aortic aneurysm growth: a meta-analysis and meta-regression of observational comparative studies Eur. J. Vasc. Endovasc. Surg. 2012 44 287 292 22824348
17. Baxter BT Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study J. Vasc. Surg. 2002 36 1 12 12096249
18. Curci JA Petrinec D Liao S Golub LM Thompson RW Pharmacologic suppression of experimental abdominal aortic aneurysms: acomparison of doxycycline and four chemically modified tetracyclines J. Vasc. Surg. 1998 28 1082 1093 9845660
19. Rhee SG Chae HZ Kim K Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling Free Radic. Biol. Med. 2005 38 1543 1552 15917183
20. Rhee SG Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins Curr. Opin. Cell Biol. 2005 17 183 189 15780595
22. Wood ZA Schroder E Robin Harris J Poole LB Structure, mechanism and regulation of peroxiredoxins Trends Biochem. Sci. 2003 28 32 40 12517450
23. Chae HZ Kim HJ Kang SW Rhee SG Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin Diabetes Res. Clin. Pract. 1999 45 101 112 10588361
24. Jeong SJ Prdx1 (peroxiredoxin 1) deficiency reduces cholesterol efflux via impaired macrophage lipophagic flux Autophagy 2018 14 120 133 28605287
25. Park JG Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice Circulation Res. 2011 109 739 749 21835911
26. Choi MH Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II Nature 2005 435 347 353 15902258
27. Urbonavicius S Proteomic identification of differentially expressed proteins in aortic wall of patients with ruptured and nonruptured abdominal aortic aneurysms J. Vasc. Surg. 2009 49 455 463 19038529
28. Daugherty A Manning MW Cassis LA Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis Br. J. Pharmacol. 2001 134 865 870 11606327
29. Ray JL Leach R Herbert JM Benson M Isolation of vascular smooth muscle cells from a single murine aorta Methods Cell Sci. 2001 23 185 188 12486328
30. Valentin F Bueb JL Kieffer P Tschirhart E Atkinson J Oxidative stress activates MMP-2 in cultured human coronary smooth muscle cells Fundam. Clin. Pharm. 2005 19 661 667
31. Clempus RE Griendling KK Reactive oxygen species signaling in vascular smooth muscle cells Cardiovascular Res. 2006 71 216 225
32. McCormick ML Gavrila D Weintraub NL Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms Arterioscler. Thromb. Vasc. Biol. 2007 27 461 469 17218601
33. Csala M On the role of 4-hydroxynonenal in health and disease Biochimica et. biophysica acta 2015 1852 826 838 25643868
34. Millett CE Phillips BE Saunders EFH The Sex-specific Effects of LPS on Depressive-like Behavior and Oxidative Stress in the Hippocampus of the Mouse Neuroscience 2019 399 77 88 30553795
35. Tretter L Patocs A Chinopoulos C Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis Biochimica et. biophysica acta 2016 1857 1086 1101 26971832
36. Lee TH Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice Blood 2003 101 5033 5038 12586629
37. Mullen L Hanschmann EM Lillig CH Herzenberg LA Ghezzi P Cysteine Oxidation Targets Peroxiredoxins 1 and 2 for Exosomal Release through a Novel Mechanism of Redox-Dependent Secretion Mol. Med 2015 21 98 108 25715249
38. Martinez-Pinna R Identification of peroxiredoxin-1 as a novel biomarker of abdominal aortic aneurysm Arterioscler. Thromb. Vasc. Biol. 2011 31 935 943 21273562
39. Ejiri J Oxidative stress in the pathogenesis of thoracic aortic aneurysm: protective role of statin and angiotensin II type 1 receptor blocker Cardiovasc. Res. 2003 59 988 996 14553839
40. Li PF Dietz R von Harsdorf R Reactive oxygen species induce apoptosis of vascular smooth muscle cell FEBS Lett. 1997 404 249 252 9119073
41. Tan S Sagara Y Liu Y Maher P Schubert D The regulation of reactive oxygen species production during programmed cell death J. Cell Biol. 1998 141 1423 1432 9628898
42. Meli DN Christen S Leib SL Matrix metalloproteinase-9 in pneumococcal meningitis: activation via an oxidative pathway J. Infect. Dis. 2003 187 1411 1415 12717622
43. Rajagopalan S Meng XP Ramasamy S Harrison DG Galis ZS Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability J. Clin. Investig. 1996 98 2572 2579 8958220
44. Longo GM Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms J. Clin. Investig. 2002 110 625 632 12208863
45. Newman KM Jean-Claude J Li H Ramey WG Tilson MD Cytokines that activate proteolysis are increased in abdominal aortic aneurysms Circulation 1994 90 II224 II227 7955258
46. Henderson EL Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms Circulation 1999 99 96 104 9884385
47. Sundaresan M Yu ZX Ferrans VJ Irani K Finkel T Requirement for generation of H2O2 for platelet-derived growth factor signal transduction Science 1995 270 296 299 7569979
48. Patel MI Ghosh P Melrose J Appleberg M Smooth muscle cell migration and proliferation is enhanced in abdominal aortic aneurysms Aust. N. Z. J. Surg. 1996 66 305 308 8634049
49. Kang DH Peroxiredoxin II is an essential antioxidant enzyme that prevents the oxidative inactivation of VEGF receptor-2 in vascular endothelial cells Mol. Cell 2011 44 545 558 22099303
50. Escobar E Rodriguez-Reyna TS Arrieta O Sotelo J Angiotensin II, cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer Curr. Vasc. Pharmacol. 2004 2 385 399 15320819
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.